Platinum Group Metals Nanoparticles in Breast Cancer Therapy.

Area of Science:

• Materials Science
• Nanotechnology
• Oncology

Background:

• Breast cancer is a leading cause of cancer-related mortality globally.
• Current breast cancer therapies face significant challenges including drug resistance, toxicity, and poor delivery.
• Nanotechnology offers novel solutions for cancer diagnosis, imaging, and therapy.

Purpose of the Study:

• To review the therapeutic potential of platinum group metal nanoparticles (PGMNs) against breast cancer.
• To discuss the advantages of PGMNs in overcoming current therapeutic limitations.
• To explore the applications and future opportunities of PGMNs in breast cancer treatment.

Main Methods:

• Review of preclinical studies on PGMNs for breast cancer therapy.
• Analysis of PGM nanoparticle properties, including stability, functionalization, and targeting capabilities.
• Discussion of PGM nanoparticle incorporation with drugs and targeting moieties.

Main Results:

• Platinum group metal nanoparticles (PGMNs) demonstrate significant efficacy against various breast cancer cells in preclinical studies.
• PGMNs offer advantages such as targeting hypoxic environments and catalyzing reactive oxygen species production.
• Incorporation of PGMNs with anticancer drugs and targeting ligands enhances therapeutic outcomes.

Conclusions:

• PGMNs represent a promising therapeutic strategy for breast cancer, addressing limitations of conventional treatments.
• Further research and clinical trials are warranted to fully realize the potential of PGMNs in breast cancer therapy.
• PGM-based nanomaterials offer diverse opportunities for future advancements in combating breast cancer.